Literature DB >> 22977542

Pulmonary alveolar proteinosis and successful therapy with combined lavage procedures: Case reports.

Nalan Demır Firat1, Aydin Cıledağ, Pinar Akin Kabalak, Demet Karnak, Başak Ceyda Meco, Zekerıyya Alanoğlu, Neslıhan Alkiş.   

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of lipoproteinaceous material within alveolar spaces. Whole-lung lavage (WLL) has been the most common therapeutic intervention for this disorder. However, patients presenting with PAP are usually hypoxemic or in poor clinical condition, and WLL may be impossible to perform. In such cases, multiple segmental lavage (MSL) may be advocated as a first-choice therapy prior to WLL. Herein, we present two cases with idiopathic PAP treated successfully with both lavage techniques consecutively. After the MSL procedure, WLL was performed, and both patients showed a marked clinical and physiologic improvement. Therefore, for patients who are not good candidates for general anesthesia, we recommend MSL (or 'prewash') before WLL to produce an increase in the blood oxygen level for long-duration general anesthesia. In the surgical room, close monitoring and repositioning of the patient as well as maintenance and inspection of the correct tube position, and manual chest wall percussion are extremely important for the safety and success of the procedure.

Entities:  

Year:  2011        PMID: 22977542      PMCID: PMC3440708          DOI: 10.3892/etm.2011.230

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  19 in total

1.  PULMONARY ALVEOLAR PROTEINOSIS. REPORT OF SIX CASES, REVIEW OF THE LITERATURE, AND FORMULATION OF A NEW THEORY.

Authors:  R K LARSON; R GORDINIER
Journal:  Ann Intern Med       Date:  1965-02       Impact factor: 25.391

2.  Treatment of a primary pulmonary alveolar proteinosis case with severe hypoxaemia by using segmental lavage technique.

Authors:  Ebru Cakir Edis; Erhan Tabakoglu; Tuncay Caglar; Osman Nuri Hatipoglu; Leyla Cevirme; Aysin Alagol
Journal:  Ann Acad Med Singap       Date:  2007-10       Impact factor: 2.473

3.  Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis.

Authors:  J F Seymour; A R Dunn; J M Vincent; J J Presneill; M C Pain
Journal:  N Engl J Med       Date:  1996-12-19       Impact factor: 91.245

4.  Pulmonary alveolar proteinosis in Israel: ethnic clustering.

Authors:  I Ben-Dov; Y Kishinevski; J Roznman; A Soliman; H Bishara; E Zelligson; J Grief; A Mazar; M Perelman; R Vishnizer; D Weiler-Ravel
Journal:  Isr Med Assoc J       Date:  1999-10       Impact factor: 0.892

Review 5.  Pulmonary alveolar proteinosis.

Authors:  J M Davidson; W M Macleod
Journal:  Br J Dis Chest       Date:  1969-01

6.  Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage.

Authors:  Shih-Lung Cheng; Hou-Tai Chang; Hon-Ping Lau; Li-Na Lee; Pan-Chyr Yang
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

7.  Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.

Authors:  J F Seymour; J J Presneill; O D Schoch; G H Downie; P E Moore; I R Doyle; J M Vincent; K Nakata; T Kitamura; D Langton; M C Pain; A R Dunn
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

8.  Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis.

Authors:  M S Kavuru; E J Sullivan; R Piccin; M J Thomassen; J K Stoller
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

9.  Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis.

Authors:  M Beccaria; M Luisetti; G Rodi; A Corsico; M C Zoia; S Colato; P Pochetti; A Braschi; E Pozzi; I Cerveri
Journal:  Eur Respir J       Date:  2004-04       Impact factor: 16.671

10.  Anaesthesia for serial whole-lung lavage in a patient with severe pulmonary alveolar proteinosis: a case report.

Authors:  Stephen T Webb; Adrian J R Evans; A James Varley; Andrew A Klein
Journal:  J Med Case Rep       Date:  2008-11-27
View more
  6 in total

1.  Novel method of noninvasive ventilation supported therapeutic lavage in pulmonary alveolar proteinosis proves to relieve dyspnea, normalize pulmonary function test results and recover exercise capacity: a short communication.

Authors:  Szymon Skoczynski; Katarzyna Wyskida; Patrycja Rzepka-Wrona; Magdalena Wyskida; Ewa Uszok-Gawel; Dawid Bartocha; Lukasz Krzych; Wladysław Pierzchala; Adam Barczyk
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  A case of autoimmune pulmonary alveolar proteinosis with severe respiratory failure treated with segmental lung lavage and oral statin therapy.

Authors:  Tomotsugu Takano; Keisuke Takeda; Satoshi Nakamura; Genta Akiyama; Nobuhisa Ando; Masashi Komori
Journal:  Respir Med Case Rep       Date:  2022-06-06

3.  Therapeutic limited bronchoalveolar lavage with fiberoptic bronchoscopy as a bridging procedure prior to total lung lavage in a patient with pulmonary alveolar proteinosis: a case report.

Authors:  Damith Rodrigo; Amila Rathnapala; Wijitha Senaratne
Journal:  J Med Case Rep       Date:  2015-04-29

4.  Pulmonary alveolar proteinosis and first successful whole lung lavage in Sri Lanka: a case report.

Authors:  Janith Galhenage; Buddhika Weerasinghe; Wadasinghe Dilesha; Roshana Constantine; Bandu Gunasena
Journal:  J Med Case Rep       Date:  2017-03-08

5.  Whole-lung lavage complicated with pneumothorax: a case report.

Authors:  Hyun-Joo Ahn; Mikyung Yang; Jie Ae Kim; Burnyoung Heo; Jin-Kyoung Kim; So Yoon Park
Journal:  Korean J Anesthesiol       Date:  2017-05-19

6.  Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia.

Authors:  Yu Matsumoto; Takeshi Masuda; Tatsuki Takahashi; Kaori Hashimoto; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Yasushi Horimasu; Taku Nakashima; Shintaro Miyamoto; Hiroshi Iwamoto; Shinichiro Ohshimo; Kazunori Fujitaka; Masahiro Yamasaki; Hironobu Hamada; Noboru Hattori
Journal:  Intern Med       Date:  2021-08-06       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.